- |||||||||| Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
Trial completion: V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) (clinicaltrials.gov) - Sep 20, 2016 P4, N=1030, Completed, Trial completion date: Apr 2018 --> May 2019 | Trial primary completion date: Apr 2018 --> Mar 2019 Active, not recruiting --> Completed
- |||||||||| Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
Enrollment closed: V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) (clinicaltrials.gov) - May 23, 2012 P4, N=1000, Active, not recruiting, Active, not recruiting --> Recruiting Recruiting --> Active, not recruiting
- |||||||||| Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
New P4 trial, Review, Journal: V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) (clinicaltrials.gov) - Mar 4, 2012 P4, N=1000, Active, not recruiting,
|